Pfizer Inc (PFE)

$25.68 -0.37 (-1.42%)
Market Cap 146.36B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.65
Forward PE 8.88
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 38,903,300
Avg Vol 38,630,813
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 4%
Beta 0.35
Analysts Sell
Price Target $29.20

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich May. 11 at 3:06 PM
$PFE alot of unknown twit heads on here in the last wee5 ! They will disappear in a short time .good luck people that understand . To those with all that garbage conspiracy junk and calling vaccines poison .BEGONE .go hang with your leader of psycho. Starts with a T and ends with little pee pee ...
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:46 PM
$PFE
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:45 PM
$PFE 🛑🛑🛑yeah jump on the bandwagon hype it up again. Inject more poison into your system. get the jabs. Everything is money money is a root of all evil. Just look at the FDA. Giving approvals opioids all the ingredients chemicals they put in your food making you obese and unhealthy. This is how they make money. They need you to be sick. Do people understand that? What a friggin joke. If you get a job, here is what you will get. Listen to Oprah Winfrey. Another free cheeseburger and french fries, very healthy.
1 · Reply
Stoxpo
Stoxpo May. 11 at 2:40 PM
Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention https://stoxpo.com/index.php/2026/05/11/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention/ $MRNA $PFE $SPY $XBI
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:40 PM
$PFE you saw what happened to the stock price when the public realized it was a failed vaccine the share price fell off a cliff everybody was selling. Now it’s time to pump it up again.! what a joke
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:39 PM
$PFE Pfizer, . Another failed vaccine pump, taking advantage. hantavirus. I wonder if we get another free, healthy french fry and cheeseburger with that JAB? The best of both worlds being injected with poison. And unhealthy gift of food.
0 · Reply
Samishere
Samishere May. 11 at 2:36 PM
$PFE
0 · Reply
dewmoore
dewmoore May. 11 at 2:35 PM
$SLS GPS: We are now 42 months since the 72nd event, and still no 80th event in sight. Simply amazing for a Phase 3 study now in its 56th month! But the KICKER is this hidden gem: SLS009 (tambiciclib). In a disease where patients are typically given 2.5 months to live, they are still alive many months later. The "Uncalculable" Success is the real story here. The CEO highlighted that in the most critical group—patients with only one prior line of therapy—the survival rate is so strong they literally cannot calculate a median overall survival (mOS) yet. Think about that: out of the 12 patients in that group, not even 7 have died since it started over a year ago. To go from a 2.5-month life expectancy to a survival trend so high it breaks the math is a MIRACLE. The nuance of this survival data in AML is the ultimate game-changer!!! LFG SLS not selling until $100 and even then won't be selling all because of the LOOMING buyout war between these 4: $LLY $PFE $MRK $ABBV
1 · Reply
nimii
nimii May. 11 at 2:35 PM
$PFE 🍽
0 · Reply
Samishere
Samishere May. 11 at 2:26 PM
$PFE
0 · Reply
Latest News on PFE
Mixed options sentiment in Pfizer with shares down 1.52%

2026-05-08T22:49:53.000Z - 2 days ago

Mixed options sentiment in Pfizer with shares down 1.52%

Mixed options sentiment in Pfizer with shares up 0.28%

2026-05-07T01:58:20.000Z - 4 days ago

Mixed options sentiment in Pfizer with shares up 0.28%

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

2026-05-05T20:09:06.000Z - 5 days ago

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 5 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 5 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

2026-05-05T15:41:20.000Z - 5 days ago

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

BNTX

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 5 days ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 days ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 6 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

PFE Earnings: Pfizer Stock Rises on Q1 Beat despite Lower 2026 Sales Outlook

2026-05-05T11:42:00.000Z - 6 days ago

PFE Earnings: Pfizer Stock Rises on Q1 Beat despite Lower 2026 Sales Outlook

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 6 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 6 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Options Volatility and Implied Earnings Moves Today, May 05, 2026

2026-05-05T11:05:22.000Z - 6 days ago

Options Volatility and Implied Earnings Moves Today, May 05, 2026

AMD BBAI ET LCID MSTR OXY PYPL

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 6 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 6 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 6 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer reports Q1 adjusted EPS 75c, consensus 72c

2026-05-05T10:48:34.000Z - 6 days ago

Pfizer reports Q1 adjusted EPS 75c, consensus 72c

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.96

2026-05-05T10:48:19.000Z - 6 days ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.96

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 6 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

Notable companies reporting before tomorrow’s open

2026-05-04T18:50:45.000Z - 6 days ago

Notable companies reporting before tomorrow’s open

ADM BUD CMI DD ETN FISV GFS

Options Volatility and Implied Earnings Moves This Week, May 04 – May 07, 2026

2026-05-04T11:00:58.000Z - 7 days ago

Options Volatility and Implied Earnings Moves This Week, May 04 – May 07, 2026

ABNB AMD ANET ARM BBAI COIN CVS

Pfizer Reports Q1 Earnings Tomorrow. What Shareholders Should Expect.

2026-05-04T10:43:31.000Z - 7 days ago

Pfizer Reports Q1 Earnings Tomorrow. What Shareholders Should Expect.

Arvinas announces FDA approval of VEPPANU for ESR1m, ER+/HER2- ABC

2026-05-01T16:51:08.000Z - 9 days ago

Arvinas announces FDA approval of VEPPANU for ESR1m, ER+/HER2- ABC

ARVN

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 9 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 12 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer reports ‘positive’ results from Phase 3 MagnetisMM-5 study

2026-04-29T11:16:25.000Z - 12 days ago

Pfizer reports ‘positive’ results from Phase 3 MagnetisMM-5 study

Pfizer price target raised to $27 from $26 at Citi

2026-04-29T10:59:57.000Z - 12 days ago

Pfizer price target raised to $27 from $26 at Citi

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 12 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 13 days ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 13 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 17 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 18 days ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 18 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 19 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 19 days ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 20 days ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 21 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 24 days ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 4 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 5 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 5 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 5 weeks ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 6 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 6 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 7 weeks ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 7 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 7 weeks ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 7 weeks ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 7 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 7 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 7 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 7 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 7 weeks ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 2 months ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 2 months ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 2 months ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 2 months ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 2 months ago

Pfizer CEO flags issues with FDA's vaccine leadership

Pfizer Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 2 months ago

Pfizer Transcript: TD Cowen 46th Annual Health Care Conference

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 2 months ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 2 months ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 2 months ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Willieberich
Willieberich May. 11 at 3:06 PM
$PFE alot of unknown twit heads on here in the last wee5 ! They will disappear in a short time .good luck people that understand . To those with all that garbage conspiracy junk and calling vaccines poison .BEGONE .go hang with your leader of psycho. Starts with a T and ends with little pee pee ...
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:46 PM
$PFE
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:45 PM
$PFE 🛑🛑🛑yeah jump on the bandwagon hype it up again. Inject more poison into your system. get the jabs. Everything is money money is a root of all evil. Just look at the FDA. Giving approvals opioids all the ingredients chemicals they put in your food making you obese and unhealthy. This is how they make money. They need you to be sick. Do people understand that? What a friggin joke. If you get a job, here is what you will get. Listen to Oprah Winfrey. Another free cheeseburger and french fries, very healthy.
1 · Reply
Stoxpo
Stoxpo May. 11 at 2:40 PM
Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention https://stoxpo.com/index.php/2026/05/11/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention/ $MRNA $PFE $SPY $XBI
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:40 PM
$PFE you saw what happened to the stock price when the public realized it was a failed vaccine the share price fell off a cliff everybody was selling. Now it’s time to pump it up again.! what a joke
0 · Reply
DarkPoolMoneyMaker
DarkPoolMoneyMaker May. 11 at 2:39 PM
$PFE Pfizer, . Another failed vaccine pump, taking advantage. hantavirus. I wonder if we get another free, healthy french fry and cheeseburger with that JAB? The best of both worlds being injected with poison. And unhealthy gift of food.
0 · Reply
Samishere
Samishere May. 11 at 2:36 PM
$PFE
0 · Reply
dewmoore
dewmoore May. 11 at 2:35 PM
$SLS GPS: We are now 42 months since the 72nd event, and still no 80th event in sight. Simply amazing for a Phase 3 study now in its 56th month! But the KICKER is this hidden gem: SLS009 (tambiciclib). In a disease where patients are typically given 2.5 months to live, they are still alive many months later. The "Uncalculable" Success is the real story here. The CEO highlighted that in the most critical group—patients with only one prior line of therapy—the survival rate is so strong they literally cannot calculate a median overall survival (mOS) yet. Think about that: out of the 12 patients in that group, not even 7 have died since it started over a year ago. To go from a 2.5-month life expectancy to a survival trend so high it breaks the math is a MIRACLE. The nuance of this survival data in AML is the ultimate game-changer!!! LFG SLS not selling until $100 and even then won't be selling all because of the LOOMING buyout war between these 4: $LLY $PFE $MRK $ABBV
1 · Reply
nimii
nimii May. 11 at 2:35 PM
$PFE 🍽
0 · Reply
Samishere
Samishere May. 11 at 2:26 PM
$PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 11 at 2:05 PM
$PFE weak as always
0 · Reply
FrankieSmilez
FrankieSmilez May. 11 at 1:52 PM
$MRNA $PFE $NVAX $SPY $JNJ
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ May. 11 at 1:49 PM
$PFE when we go green by 1%..
0 · Reply
itsfloridaking
itsfloridaking May. 11 at 1:44 PM
$PFE stay patient you little dumb shits ..
0 · Reply
hi_tech_lowlife
hi_tech_lowlife May. 11 at 1:31 PM
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb $MRNA $NVAX $PFE https://www.benzinga.com/trading-ideas/movers/26/05/52447316/hantavirus-scare-sparks-vaccine-stock-rally-moderna-novavax-climb
0 · Reply
biolover
biolover May. 11 at 1:21 PM
$VKTX $RHHBY not presenting their phase 2 at ADA ? I thought they said they would ? They left us confused on what caused the gap between treatment and efficacy estimands ? Poor tolerability ? Or placebo switching to SOC. I understand not showing tolerability numbers. But why not showing placebo performance. ? Also no presentation from $AMGN Amgen still top obesity M&A candidate. They stated before “ all in “ although I sense different all in from $PFE Bourla”s
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 11 at 1:07 PM
The Next Generation of the GLP-1 Revolution Is Already Underway $SURE.CN $SURNF $LLY $NVO $AMGN $PFE https://ibn.fm/dR7Tw
0 · Reply
nimii
nimii May. 11 at 1:06 PM
$PFE look at moderna , look at us 😡
0 · Reply
BioRich
BioRich May. 11 at 12:11 PM
$XBI BREAKING!!! Fractyl Health, $GUTS, has been authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes This is massive folks. $GUTS also has landmark pivotal data coming this year for their weight loss retention treatment. #1 Bio in our portfolio, and for good reason. If you don't know about Fractyl ($GUTS) yet, this might be a good time to start taking a look. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers! $LLY $NVO $PFE
0 · Reply
gfec
gfec May. 11 at 11:03 AM
$PFE
0 · Reply
NomadiCapital
NomadiCapital May. 11 at 10:42 AM
$PFE will become one of the easiest buys in the market if we get a Weekly oversold reading. The last 2 times Pfizer had: 1) Up-sloping 50 WMA (after long period of DownS) 2) Weekly oversold conditions .. was 2010 & 2021.. and both marked major bottoms This time is even more interesting because we also have: 3) RSI divergence 4) Highest dividend yield in company history All lining up in one spot. If Weekly goes oversold, this becomes my largest position.
1 · Reply
TheUnmaker
TheUnmaker May. 11 at 9:53 AM
$TNXP When news? $PFE $PG $JNJ $LLY https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-secures-commercial-payer-coverage-for-tonmya-wz6dr9qu3p55.html
0 · Reply